We are live on ! Find out more
TOVX icon

Theriva Biologics
TOVX

10 hedge funds and large institutions have $60.3K invested in Theriva Biologics in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

35.22% less ownership

Funds ownership: 36.46% → 1.24% (-35%)

44% less funds holding

Funds holding: 18 → 10 (-8)

78% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 9

91% less capital invested

Capital invested by funds: $679K → $60.3K (-$618K)

Holders
10
Holders Change
-8
Holders Change %
-44.44%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
2
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
+$11.3K
2
TRCT
Tower Research Capital (TRC)
New York
+$1.07K
3
Bank of America
Bank of America
North Carolina
+$16

Top Sellers

Rank Fund Capital Flow
1
HCM
Heights Capital Management
California
-$196K
2
AFM
Anson Funds Management
Texas
-$192K
3
AC
Armistice Capital
New York
-$138K
4
MP
MSD Partners
New York
-$37.7K
5
Morgan Stanley
Morgan Stanley
New York
-$27.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$28.7K -$2.11K -1,445 -8%
Citigroup
2
Citigroup
New York
$13.6K +$11.3K +7,756 New
BlackRock
3
BlackRock
New York
$13.2K – – –
TRCT
4
Tower Research Capital (TRC)
New York
$2.44K +$1.07K +730 +110%
Osaic Holdings
5
Osaic Holdings
Arizona
$2.26K – – –
Bank of America
6
Bank of America
North Carolina
$35 +$16 +11 +122%
IHWM
7
Iron Horse Wealth Management
Iowa
$25 – – –
IA
8
IFP Advisors
Florida
$19 -$433 -296 -96%
SS
9
SBI Securities
Japan
$18 +$15 +10 New
DB
10
Danske Bank
Denmark
$2 – – –
HCM
11
Heights Capital Management
California
– -$196K -141,958 Closed
AFM
12
Anson Funds Management
Texas
– -$192K -139,046 Closed
AC
13
Armistice Capital
New York
– -$138K -100,000 Closed
MP
14
MSD Partners
New York
– -$37.7K -27,316 Closed
Morgan Stanley
15
Morgan Stanley
New York
– -$27.9K -20,200 Closed
Two Sigma Investments
16
Two Sigma Investments
New York
– -$18.7K -13,566 Closed
HF
17
HRT Financial
New York
– -$16K -11,806 Closed
TSS
18
Two Sigma Securities
New York
– -$14K -10,120 Closed
Barclays
19
Barclays
United Kingdom
– -$683 -495 Closed

TOVX Hedge Fund Activity: Q4 2024 in Review

10 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Theriva Biologics (TOVX) for Q4 2024, worth a combined $60.3K — down 91% from $679K a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of TOVX and 2 opened new positions — a net loss of 7 holders — while 2 trimmed existing stakes and 2 added.

The largest buyer was Citigroup, opening a new position worth an estimated $11.3K. The largest seller was Heights Capital Management, exiting entirely with an estimated $196K sold.

  • 10 institutional investors held Theriva Biologics (TOVX) as of Q4 2024, down from 18 in Q3 2024.
  • Funds reported $60.3K of Theriva Biologics stock for Q4 2024, down 91% quarter-over-quarter.
  • 2 funds opened new Theriva Biologics positions in Q4 2024 and 9 closed out, a net change of -7 holders.
  • The largest Theriva Biologics buyer in Q4 2024 was Citigroup, an estimated $11.3K added.
  • The largest Theriva Biologics seller in Q4 2024 was Heights Capital Management, an estimated $196K sold.

Based on aggregated 13F filings for Q4 2024.